Newly Approved Oral Medication Slows Rheumatoid Arthritis Joint Damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis patients who did not respond to methotrexate .
Join the discussion below, or Read more at MediLexicon.
Since: Jan 13
#1 Jan 25, 2013
This could be great information for arthritis people.Thanks for information.
#2 Apr 1, 2013
Wow this is amazing if it really slows down the effects of arthritis. I have read somewhere at depuypinnaclelawsuit. com that there may be some preoblems with hip replacements so this is a new alternative.
Add your comments below
|Trump's HHS removes all mention of lesbian and ...||5 min||Logic Analysis||6|
|i need an abortionist near metro manila (Feb '11)||2 hr||Joesp||52|
|Hemorrhoids Home Treatment (Jan '13)||2 hr||dolige||93|
|Antibiotics are still the treatment of choice f... (Dec '07)||10 hr||Merritt||220|
|Diabetes Complications: What's Your Risk? (Jun '07)||12 hr||Jesus Pimpsoul||5|
|Q&A: Losing Erection When Masturbating: Is That... (Apr '10)||12 hr||Knox||18|
|stress fractures to various body parts||13 hr||marleo12||2|
Find what you want!
Search Health Forum Now
Copyright © 2018 Topix LLC